 | • レポートコード：QFJ1-4970 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、経皮パッチ薬物送達システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シャントウェイ、細胞間脂質構造経路、トランスセルラー経路）、用途別市場規模（病院、クリニック、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・経皮パッチ薬物送達システムの市場動向 ・企業の競争状況、市場シェア ・経皮パッチ薬物送達システムの種類別市場規模と予測2016-2027（シャントウェイ、細胞間脂質構造経路、トランスセルラー経路） ・経皮パッチ薬物送達システムの用途別市場規模と予測2016-2027（病院、クリニック、在宅医療、その他） ・経皮パッチ薬物送達システムの北米市場規模2016-2027（アメリカ、カナダ） ・経皮パッチ薬物送達システムの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・経皮パッチ薬物送達システムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・経皮パッチ薬物送達システムの中南米市場規模2016-2027（メキシコ、ブラジル） ・経皮パッチ薬物送達システムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Hisamitsu Pharmaceutical、Novartis、ProSolus、Tapemark、Tesa Labtec、NITTO DENKO CORPORATION、Noven Pharmaceuticals、LTS Lohmann Therapie-Systeme、Medherant、Corium、Antares Pharma、Syntropharma、Teikoku Pharma、Mylan、Actavis、Mundipharma、Henan Lingrui Pharmaceutical、Changzhou Siyao、Rfl Pharmaceutical） ・結論 |
Transdermal patches drug delivery system are a method of delivering drugs directly through the skin into the bloodstream.It mainly has polymer matrix, drug, penetration accelerator and adhesive layer.Patches can provide controlled, continuous administration of drugs that are easy to eat with minimal side effects and non-invasive.Compared to injectable and oral systems, it avoids first-pass metabolism and is easy to maintain drug concentration, ensuring that drugs reach the body with minimal side effects, ensuring good adhesion and effective release through the skin in the form of skin circulation for hours or days.
Market Analysis and Insights: Global Transdermal Patch Drug Delivery System Market
The global Transdermal Patch Drug Delivery System market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal Patch Drug Delivery System market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal Patch Drug Delivery System market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal Patch Drug Delivery System market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal Patch Drug Delivery System market.
Global Transdermal Patch Drug Delivery System Scope and Market Size
Transdermal Patch Drug Delivery System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Patch Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Shunt Way
Intercellular Lipid Structure Pathway
Trans-cellular Pathway
Segment by Application
Hospital
Clinic
Home Care
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Hisamitsu Pharmaceutical
Novartis
ProSolus
Tapemark
Tesa Labtec
NITTO DENKO CORPORATION
Noven Pharmaceuticals
LTS Lohmann Therapie-Systeme
Medherant
Corium
Antares Pharma
Syntropharma
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Shunt Way
1.2.3 Intercellular Lipid Structure Pathway
1.2.4 Trans-cellular Pathway
1.3 Market by Application
1.3.1 Global Transdermal Patch Drug Delivery System Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Patch Drug Delivery System Market Perspective (2016-2027)
2.2 Transdermal Patch Drug Delivery System Growth Trends by Regions
2.2.1 Transdermal Patch Drug Delivery System Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transdermal Patch Drug Delivery System Historic Market Share by Regions (2016-2021)
2.2.3 Transdermal Patch Drug Delivery System Forecasted Market Size by Regions (2022-2027)
2.3 Transdermal Patch Drug Delivery System Industry Dynamic
2.3.1 Transdermal Patch Drug Delivery System Market Trends
2.3.2 Transdermal Patch Drug Delivery System Market Drivers
2.3.3 Transdermal Patch Drug Delivery System Market Challenges
2.3.4 Transdermal Patch Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue
3.1.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue (2016-2021)
3.1.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by Players (2016-2021)
3.2 Global Transdermal Patch Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transdermal Patch Drug Delivery System Revenue
3.4 Global Transdermal Patch Drug Delivery System Market Concentration Ratio
3.4.1 Global Transdermal Patch Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Patch Drug Delivery System Revenue in 2020
3.5 Transdermal Patch Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Transdermal Patch Drug Delivery System Product Solution and Service
3.7 Date of Enter into Transdermal Patch Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Patch Drug Delivery System Breakdown Data by Type
4.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Type (2016-2021)
4.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2022-2027)
5 Transdermal Patch Drug Delivery System Breakdown Data by Application
5.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Application (2016-2021)
5.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Transdermal Patch Drug Delivery System Market Size (2016-2027)
6.2 North America Transdermal Patch Drug Delivery System Market Size by Type
6.2.1 North America Transdermal Patch Drug Delivery System Market Size by Type (2016-2021)
6.2.2 North America Transdermal Patch Drug Delivery System Market Size by Type (2022-2027)
6.2.3 North America Transdermal Patch Drug Delivery System Market Size by Type (2016-2027)
6.3 North America Transdermal Patch Drug Delivery System Market Size by Application
6.3.1 North America Transdermal Patch Drug Delivery System Market Size by Application (2016-2021)
6.3.2 North America Transdermal Patch Drug Delivery System Market Size by Application (2022-2027)
6.3.3 North America Transdermal Patch Drug Delivery System Market Size by Application (2016-2027)
6.4 North America Transdermal Patch Drug Delivery System Market Size by Country
6.4.1 North America Transdermal Patch Drug Delivery System Market Size by Country (2016-2021)
6.4.2 North America Transdermal Patch Drug Delivery System Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Transdermal Patch Drug Delivery System Market Size (2016-2027)
7.2 Europe Transdermal Patch Drug Delivery System Market Size by Type
7.2.1 Europe Transdermal Patch Drug Delivery System Market Size by Type (2016-2021)
7.2.2 Europe Transdermal Patch Drug Delivery System Market Size by Type (2022-2027)
7.2.3 Europe Transdermal Patch Drug Delivery System Market Size by Type (2016-2027)
7.3 Europe Transdermal Patch Drug Delivery System Market Size by Application
7.3.1 Europe Transdermal Patch Drug Delivery System Market Size by Application (2016-2021)
7.3.2 Europe Transdermal Patch Drug Delivery System Market Size by Application (2022-2027)
7.3.3 Europe Transdermal Patch Drug Delivery System Market Size by Application (2016-2027)
7.4 Europe Transdermal Patch Drug Delivery System Market Size by Country
7.4.1 Europe Transdermal Patch Drug Delivery System Market Size by Country (2016-2021)
7.4.2 Europe Transdermal Patch Drug Delivery System Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size (2016-2027)
8.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type
8.2.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type (2016-2027)
8.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application
8.3.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application (2016-2027)
8.4 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region
8.4.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transdermal Patch Drug Delivery System Market Size (2016-2027)
9.2 Latin America Transdermal Patch Drug Delivery System Market Size by Type
9.2.1 Latin America Transdermal Patch Drug Delivery System Market Size by Type (2016-2021)
9.2.2 Latin America Transdermal Patch Drug Delivery System Market Size by Type (2022-2027)
9.2.3 Latin America Transdermal Patch Drug Delivery System Market Size by Type (2016-2027)
9.3 Latin America Transdermal Patch Drug Delivery System Market Size by Application
9.3.1 Latin America Transdermal Patch Drug Delivery System Market Size by Application (2016-2021)
9.3.2 Latin America Transdermal Patch Drug Delivery System Market Size by Application (2022-2027)
9.3.3 Latin America Transdermal Patch Drug Delivery System Market Size by Application (2016-2027)
9.4 Latin America Transdermal Patch Drug Delivery System Market Size by Country
9.4.1 Latin America Transdermal Patch Drug Delivery System Market Size by Country (2016-2021)
9.4.2 Latin America Transdermal Patch Drug Delivery System Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size (2016-2027)
10.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type
10.2.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type (2016-2027)
10.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application
10.3.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2016-2027)
10.4 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country
10.4.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Company Details
11.1.2 Hisamitsu Pharmaceutical Business Overview
11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.1.4 Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Transdermal Patch Drug Delivery System Introduction
11.2.4 Novartis Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 ProSolus
11.3.1 ProSolus Company Details
11.3.2 ProSolus Business Overview
11.3.3 ProSolus Transdermal Patch Drug Delivery System Introduction
11.3.4 ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.3.5 ProSolus Recent Development
11.4 Tapemark
11.4.1 Tapemark Company Details
11.4.2 Tapemark Business Overview
11.4.3 Tapemark Transdermal Patch Drug Delivery System Introduction
11.4.4 Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.4.5 Tapemark Recent Development
11.5 Tesa Labtec
11.5.1 Tesa Labtec Company Details
11.5.2 Tesa Labtec Business Overview
11.5.3 Tesa Labtec Transdermal Patch Drug Delivery System Introduction
11.5.4 Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.5.5 Tesa Labtec Recent Development
11.6 NITTO DENKO CORPORATION
11.6.1 NITTO DENKO CORPORATION Company Details
11.6.2 NITTO DENKO CORPORATION Business Overview
11.6.3 NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Introduction
11.6.4 NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.6.5 NITTO DENKO CORPORATION Recent Development
11.7 Noven Pharmaceuticals
11.7.1 Noven Pharmaceuticals Company Details
11.7.2 Noven Pharmaceuticals Business Overview
11.7.3 Noven Pharmaceuticals Transdermal Patch Drug Delivery System Introduction
11.7.4 Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.7.5 Noven Pharmaceuticals Recent Development
11.8 LTS Lohmann Therapie-Systeme
11.8.1 LTS Lohmann Therapie-Systeme Company Details
11.8.2 LTS Lohmann Therapie-Systeme Business Overview
11.8.3 LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Introduction
11.8.4 LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.8.5 LTS Lohmann Therapie-Systeme Recent Development
11.9 Medherant
11.9.1 Medherant Company Details
11.9.2 Medherant Business Overview
11.9.3 Medherant Transdermal Patch Drug Delivery System Introduction
11.9.4 Medherant Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.9.5 Medherant Recent Development
11.10 Corium
11.10.1 Corium Company Details
11.10.2 Corium Business Overview
11.10.3 Corium Transdermal Patch Drug Delivery System Introduction
11.10.4 Corium Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.10.5 Corium Recent Development
11.11 Antares Pharma
11.11.1 Antares Pharma Company Details
11.11.2 Antares Pharma Business Overview
11.11.3 Antares Pharma Transdermal Patch Drug Delivery System Introduction
11.11.4 Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.11.5 Antares Pharma Recent Development
11.12 Syntropharma
11.12.1 Syntropharma Company Details
11.12.2 Syntropharma Business Overview
11.12.3 Syntropharma Transdermal Patch Drug Delivery System Introduction
11.12.4 Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.12.5 Syntropharma Recent Development
11.13 Teikoku Pharma
11.13.1 Teikoku Pharma Company Details
11.13.2 Teikoku Pharma Business Overview
11.13.3 Teikoku Pharma Transdermal Patch Drug Delivery System Introduction
11.13.4 Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.13.5 Teikoku Pharma Recent Development
11.14 Mylan
11.14.1 Mylan Company Details
11.14.2 Mylan Business Overview
11.14.3 Mylan Transdermal Patch Drug Delivery System Introduction
11.14.4 Mylan Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.14.5 Mylan Recent Development
11.15 Actavis
11.15.1 Actavis Company Details
11.15.2 Actavis Business Overview
11.15.3 Actavis Transdermal Patch Drug Delivery System Introduction
11.15.4 Actavis Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.15.5 Actavis Recent Development
11.16 Mundipharma
11.16.1 Mundipharma Company Details
11.16.2 Mundipharma Business Overview
11.16.3 Mundipharma Transdermal Patch Drug Delivery System Introduction
11.16.4 Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.16.5 Mundipharma Recent Development
11.17 Henan Lingrui Pharmaceutical
11.17.1 Henan Lingrui Pharmaceutical Company Details
11.17.2 Henan Lingrui Pharmaceutical Business Overview
11.17.3 Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.17.4 Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.17.5 Henan Lingrui Pharmaceutical Recent Development
11.18 Changzhou Siyao
11.18.1 Changzhou Siyao Company Details
11.18.2 Changzhou Siyao Business Overview
11.18.3 Changzhou Siyao Transdermal Patch Drug Delivery System Introduction
11.18.4 Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
11.18.5 Changzhou Siyao Recent Development
11.18 Rfl Pharmaceutical
.1 Rfl Pharmaceutical Company Details
.2 Rfl Pharmaceutical Business Overview
.3 Rfl Pharmaceutical Transdermal Patch Drug Delivery System Introduction
.4 Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2016-2021)
.5 Rfl Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Shunt Way
Table 3. Key Players of Intercellular Lipid Structure Pathway
Table 4. Key Players of Trans-cellular Pathway
Table 5. Global Transdermal Patch Drug Delivery System Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Transdermal Patch Drug Delivery System Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Transdermal Patch Drug Delivery System Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Transdermal Patch Drug Delivery System Market Share by Regions (2016-2021)
Table 9. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Transdermal Patch Drug Delivery System Market Share by Regions (2022-2027)
Table 11. Transdermal Patch Drug Delivery System Market Trends
Table 12. Transdermal Patch Drug Delivery System Market Drivers
Table 13. Transdermal Patch Drug Delivery System Market Challenges
Table 14. Transdermal Patch Drug Delivery System Market Restraints
Table 15. Global Transdermal Patch Drug Delivery System Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Transdermal Patch Drug Delivery System Market Share by Players (2016-2021)
Table 17. Global Top Transdermal Patch Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch Drug Delivery System as of 2020)
Table 18. Ranking of Global Top Transdermal Patch Drug Delivery System Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Transdermal Patch Drug Delivery System Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Transdermal Patch Drug Delivery System Product Solution and Service
Table 22. Date of Enter into Transdermal Patch Drug Delivery System Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Transdermal Patch Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2016-2021)
Table 26. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Transdermal Patch Drug Delivery System Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Transdermal Patch Drug Delivery System Revenue Market Share by Application (2016-2021)
Table 30. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Transdermal Patch Drug Delivery System Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Transdermal Patch Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Transdermal Patch Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Transdermal Patch Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Transdermal Patch Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Transdermal Patch Drug Delivery System Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Transdermal Patch Drug Delivery System Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Transdermal Patch Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Transdermal Patch Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Transdermal Patch Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Transdermal Patch Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Transdermal Patch Drug Delivery System Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Transdermal Patch Drug Delivery System Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Transdermal Patch Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Transdermal Patch Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Transdermal Patch Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Transdermal Patch Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Transdermal Patch Drug Delivery System Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Transdermal Patch Drug Delivery System Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2022-2027) & (US$ Million)
Table 62. Hisamitsu Pharmaceutical Company Details
Table 63. Hisamitsu Pharmaceutical Business Overview
Table 64. Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Product
Table 65. Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 66. Hisamitsu Pharmaceutical Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Transdermal Patch Drug Delivery System Product
Table 70. Novartis Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. ProSolus Company Details
Table 73. ProSolus Business Overview
Table 74. ProSolus Transdermal Patch Drug Delivery System Product
Table 75. ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 76. ProSolus Recent Development
Table 77. Tapemark Company Details
Table 78. Tapemark Business Overview
Table 79. Tapemark Transdermal Patch Drug Delivery System Product
Table 80. Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 81. Tapemark Recent Development
Table 82. Tesa Labtec Company Details
Table 83. Tesa Labtec Business Overview
Table 84. Tesa Labtec Transdermal Patch Drug Delivery System Product
Table 85. Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 86. Tesa Labtec Recent Development
Table 87. NITTO DENKO CORPORATION Company Details
Table 88. NITTO DENKO CORPORATION Business Overview
Table 89. NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Product
Table 90. NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 91. NITTO DENKO CORPORATION Recent Development
Table 92. Noven Pharmaceuticals Company Details
Table 93. Noven Pharmaceuticals Business Overview
Table 94. Noven Pharmaceuticals Transdermal Patch Drug Delivery System Product
Table 95. Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 96. Noven Pharmaceuticals Recent Development
Table 97. LTS Lohmann Therapie-Systeme Company Details
Table 98. LTS Lohmann Therapie-Systeme Business Overview
Table 99. LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 100. LTS Lohmann Therapie-Systeme Recent Development
Table 101. Medherant Company Details
Table 102. Medherant Business Overview
Table 103. Medherant Transdermal Patch Drug Delivery System Product
Table 104. Medherant Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 105. Medherant Recent Development
Table 106. Corium Company Details
Table 107. Corium Business Overview
Table 108. Corium Transdermal Patch Drug Delivery System Product
Table 109. Corium Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 110. Corium Recent Development
Table 111. Antares Pharma Company Details
Table 112. Antares Pharma Business Overview
Table 113. Antares Pharma Transdermal Patch Drug Delivery System Product
Table 114. Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 115. Antares Pharma Recent Development
Table 116. Syntropharma Company Details
Table 117. Syntropharma Business Overview
Table 118. Syntropharma Transdermal Patch Drug Delivery System Product
Table 119. Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 120. Syntropharma Recent Development
Table 121. Teikoku Pharma Company Details
Table 122. Teikoku Pharma Business Overview
Table 123. Teikoku Pharma Transdermal Patch Drug Delivery System Product
Table 124. Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 125. Teikoku Pharma Recent Development
Table 126. Mylan Company Details
Table 127. Mylan Business Overview
Table 128. Mylan Transdermal Patch Drug Delivery System Product
Table 129. Mylan Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 130. Mylan Recent Development
Table 131. Actavis Company Details
Table 132. Actavis Business Overview
Table 133. Actavis Transdermal Patch Drug Delivery System Product
Table 134. Actavis Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 135. Actavis Recent Development
Table 136. Mundipharma Company Details
Table 137. Mundipharma Business Overview
Table 138. Mundipharma Transdermal Patch Drug Delivery System Product
Table 139. Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 140. Mundipharma Recent Development
Table 141. Henan Lingrui Pharmaceutical Company Details
Table 142. Henan Lingrui Pharmaceutical Business Overview
Table 143. Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Product
Table 144. Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 145. Henan Lingrui Pharmaceutical Recent Development
Table 146. Changzhou Siyao Company Details
Table 147. Changzhou Siyao Business Overview
Table 148. Changzhou Siyao Transdermal Patch Drug Delivery System Product
Table 149. Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 150. Changzhou Siyao Recent Development
Table 151. Rfl Pharmaceutical Company Details
Table 152. Rfl Pharmaceutical Business Overview
Table 153. Rfl Pharmaceutical Transdermal Patch Drug Delivery System Product
Table 154. Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2016-2021) & (US$ Million)
Table 155. Rfl Pharmaceutical Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Patch Drug Delivery System Market Share by Type: 2020 VS 2027
Figure 2. Shunt Way Features
Figure 3. Intercellular Lipid Structure Pathway Features
Figure 4. Trans-cellular Pathway Features
Figure 5. Global Transdermal Patch Drug Delivery System Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Home Care Case Studies
Figure 9. Other Case Studies
Figure 10. Transdermal Patch Drug Delivery System Report Years Considered
Figure 11. Global Transdermal Patch Drug Delivery System Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Transdermal Patch Drug Delivery System Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Transdermal Patch Drug Delivery System Market Share by Regions: 2020 VS 2027
Figure 14. Global Transdermal Patch Drug Delivery System Market Share by Regions (2022-2027)
Figure 15. Global Transdermal Patch Drug Delivery System Market Share by Players in 2020
Figure 16. Global Top Transdermal Patch Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch Drug Delivery System as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Transdermal Patch Drug Delivery System Revenue in 2020
Figure 18. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2016-2021)
Figure 19. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2022-2027)
Figure 20. North America Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Transdermal Patch Drug Delivery System Market Share by Type (2016-2027)
Figure 22. North America Transdermal Patch Drug Delivery System Market Share by Application (2016-2027)
Figure 23. North America Transdermal Patch Drug Delivery System Market Share by Country (2016-2027)
Figure 24. United States Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Transdermal Patch Drug Delivery System Market Share by Type (2016-2027)
Figure 28. Europe Transdermal Patch Drug Delivery System Market Share by Application (2016-2027)
Figure 29. Europe Transdermal Patch Drug Delivery System Market Share by Country (2016-2027)
Figure 30. Germany Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Transdermal Patch Drug Delivery System Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Transdermal Patch Drug Delivery System Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Transdermal Patch Drug Delivery System Market Share by Region (2016-2027)
Figure 40. China Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Transdermal Patch Drug Delivery System Market Share by Type (2016-2027)
Figure 48. Latin America Transdermal Patch Drug Delivery System Market Share by Application (2016-2027)
Figure 49. Latin America Transdermal Patch Drug Delivery System Market Share by Country (2016-2027)
Figure 50. Mexico Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Transdermal Patch Drug Delivery System Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Transdermal Patch Drug Delivery System Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Transdermal Patch Drug Delivery System Market Share by Country (2016-2027)
Figure 56. Turkey Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Transdermal Patch Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Hisamitsu Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 61. ProSolus Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 62. Tapemark Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 63. Tesa Labtec Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 64. NITTO DENKO CORPORATION Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 65. Noven Pharmaceuticals Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 66. LTS Lohmann Therapie-Systeme Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 67. Medherant Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 68. Corium Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 69. Antares Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 70. Syntropharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 71. Teikoku Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 72. Mylan Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 73. Actavis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 74. Mundipharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 75. Henan Lingrui Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 76. Changzhou Siyao Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 77. Rfl Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
世界の経皮薬物送達システム市場規模・現状・予測（2021年-2027年） Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other type…- 経皮ニコチンパッチのグローバル市場調査 2019年 The global Transdermal Nicotine Patch market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Transdermal Nicotine Patch volume and value at global level, regional level and company level. From a global per…
- 経皮ニコチンパッチのグローバル市場調査 2019年 The global Transdermal Nicotine Patch market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Transdermal Nicotine Patch volume and value at global level, regional level and company level. From a global per…
- 世界の小分子ドラッグデリバリー市場規模・現状・予測（2021年-2027年） The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities …
- 経皮皮膚パッチのグローバル市場調査 2019年 The global Transdermal Skin Patch market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Transdermal Skin Patch volume and value at global level, regional level and company level. From a global perspective…